Sof marja: Precision BioSciences, Inc. (DTIL)

DTIL (Precision BioSciences) - kompaniyaning tovar belgisi

GURU.Markets servisidan olingan ushbu Precision BioSciences (DTIL) grafigidagi har bir rubl daromadga nisbatan sof marja bozor kutganlarini namoyish etadi, bunda -87.50 qiymati ushbu holatni aks ettiradi. Ushbu tendentsiya ARCUS platformasiga tikilgan garov va tadqiqotlar hamda ishlanmalar (R&D)ga akademik yondashuv bilan boshqarilmoqda. Model ichki ishlab chiqarishsiz AI yechimlariga asoslangan. Kalibrlangan diagnostika tizimlari va shartnomaviy ishlab chiqarish zavodlarining rezerv imkoniyatlari barqarorlikni ta'minlaydi.

precisionbiosciences.com (DTIL) Kompaniya sotuv marjasi: 04.07.2022 - 19.11.2026 davri uchun

Precision BioSciences, Inc. (DTIL) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- aksiya kursi va ekspertlarning narx prognozi:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:Precision BioSciences
precisionbiosciences.com yetakchi tovari

Sotuv marjalari jami daromadning sof foyda ulushini belgilab, barcha savdo operatsiyalarining yakuniy samaradorligini aks ettiradi. Ushbu metrika barqaror operatsion foydani qisqa muddatli bozor anomaliyalaridan ajratib ko'rsatadi. Haqiqiy sof foyda marjalarini tahlil qilish orqali investor xarajatlar tendentsiyasini va biznesning narx belgilash imkoniyatlarini kuzatishi mumkin. Precision BioSciences (DTIL) uchun ushbu ko'rsatkich ARCUS AI platformalarini joriy etish xarajatlarini aks ettiradi. Genom bioskriningini avtomatlashtirish xarajatlarni kamaytirishi, natijada rentabellikni barqarorlashtirishi kerak.

Muhim raqobatchilar

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|Beam Tx - Sotuvning sof marjinal rentabelligi|SRPT - Sotuvning sof marjinal rentabelligi|TWST (Twist Bio) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi TXG|Sof foyda bo'yicha sotuv rentabelligi NTLA|Stoke Therapeutics Inc (STOK) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi BLFS|Sof marja WVE (Wave Life Sciences Corp)|Sof marja Maze Therapeutics MAZE|Sof foyda normasi SION|PRME - Sof marja|Kompaniya sotuv marjasi Taysha TSHA|QURE: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MeiraGTx PLC|RGNX (REGENXBIO Inc) - Sotuvning sof marjinal rentabelligi|solidbio.com (SLDB) - Kompaniya sotuv marjasi|Sof marja Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Sotuvning sof rentabelligi|Benitec Biopharma - Sof foyda bo'yicha sotuv rentabelligi|DSGN: Sotuvning sof rentabelligi|RCKT: Sof foyda bo'yicha sotuv rentabelligi|FDMT - Sotuvning sof marjinal rentabelligi|LXEO: Sotuvning sof marjinal rentabelligi|Korro Bio Inc. - Sof foyda normasi|EDIT (editasmedicine.com) - Sotuvning sof marjinal rentabelligi|Sof marja SLN|Sof marja ProQR Therapeutics NV (PRQR)|Codexis - Sotuvning sof rentabelligi|Sof marja Sangamo SGMO|NAUT: Sotuvning sof rentabelligi|MGX: Sof foyda bo'yicha sotuv rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX